Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
NN-9041 by Novo Nordisk for Type 1 Diabetes (Juvenile Diabetes): Likelihood of Approval
NN-9041 is under clinical development by Novo Nordisk and currently in Phase I for Type 1 Diabetes (Juvenile Diabetes). According...